Drugs used in Diabetes

Composition:
Each 1 ml contains: ‎
Recombinant human insulin 12 or 30 IU
‎Recombinant human Protamine-insulin 28 or 70 IU

Indications:
‎Diabetes mellitus type I: (insulin dependant) in children and adults.
‎Diabetes mellitus type II :( non insulin dependant) at th...

- Active substance(s): Metformin
- Pharmaceutical form(s): Tablets
- Strength(s): 500 mg; 850 mg; 1000 mg

In case of subcutaneous injection, the drug begins to act within 30 minutes, reaches its maximum effect within the period from 1-3 hours after injection. Duration of action is 8 hours.
Profile of the drug action depends on dosage and reflects significant individual features.

Indications:
...

Insulin H NPH 100 IU Injection

- Active substance(s): Dapaglifozin
- Pharmaceutical form(s): Tablets
- Strength(s): 5 mg; 10 mg

- Active substance(s): Dapaglifozin + Metformin
- Pharmaceutical form(s): Tablets
- Strength(s): 5mg + 850 mg; 5mg + 1000 mg

;- Active substance(s): Linagliptin
- Pharmaceutical form(s): Tablets
- Strength(s): 5 mg

- Active substance(s): Linagliptin + Metformin;
- Pharmaceutical form(s): Tablets
- Strength(s): 2,5mg + 850 mg; 2,5mg +1000mg

- Active substance(s): Sitagliptin + Metformin
- Pharmaceutical form(s): Tablets
- Strength(s): Tablets 50 mg + 850 mg; 50 mg + 1000 mg

ATB-101 Incrementally Modified Drug (FDC, T2DM + HTN)

ATB-101 improves drug compliance of elderly patients who suffer from two chronic diseases; Diabetes and Hypertension, and to reduce undesirable effects from taking multiple drugs.

Key features
-     ...